BBIO BridgeBio Pharma, Inc.

Fundamentals / CIK 0001743881 / USD

BridgeBio Pharma, Inc. reported $945.5M in revenue and a net loss of $565.8M for the trailing twelve months ended September 30, 2026 (up 192.6% year over year), with a 94.3% gross margin and a -38.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$571.4M$285.7M$0-$720.5MFY 2017 Net Income: -$30.57M2017FY 2018 Net Income: -$130.7M2018FY 2019 Revenue: $40.56MFY 2019 Net Income: -$260.6M2019FY 2020 Revenue: $8.25MFY 2020 Net Income: -$448.7M2020FY 2021 Revenue: $69.72MFY 2021 Net Income: -$562.5M2021FY 2022 Revenue: $77.65MFY 2022 Net Income: -$481.2M2022FY 2023 Revenue: $9.30MFY 2023 Net Income: -$643.2M2023FY 2024 Revenue: $221.9MFY 2024 Net Income: -$535.8M2024FY 2025 Revenue: $502.1MFY 2025 Net Income: -$724.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $502.1M $221.9M $9.30M $77.65M $69.72M $8.25M $40.56M -- --
Cost of Revenue $20.96M $3.88M $2.45M $3.43M $3.11M -- -- -- --
Gross Profit $481.1M $218.0M $6.86M $74.21M $66.60M -- -- -- --
Research & Development $452.0M $506.5M $455.7M $399.5M $451.0M $337.0M $209.9M $140.1M $30.56M
Selling, General & Admin $531.2M $288.9M $150.6M $143.2M $192.2M $145.7M $94.35M -- --
Total Operating Expenses -- -- -- -- -- $482.7M $306.8M $183.7M $43.86M
Operating Income -$523.4M -$593.0M -$607.4M -$512.2M -$576.6M -$474.5M -$266.2M -$183.7M -$43.86M
EBITDA -$518.0M -$586.9M -$600.9M -$505.4M -$570.8M -$473.0M -$265.4M -- --
Interest Income $19.85M $17.25M $18.04M $7.54M $1.13M $4.01M $8.91M $2.00M $39K
Interest Expense $53.10M $90.99M $81.29M $80.44M $46.78M $36.66M $8.77M $2.55M $13K
Income Before Tax -$732.5M -$542.2M -$653.3M -$484.7M -- $505.5M $288.6M $169.5M $43.83M
Income Tax Expense $435K $1.15M $0 $0 -- -- -- -- --
Net Income -$724.9M -$535.8M -$643.2M -$481.2M -$562.5M -$448.7M -$260.6M -$130.7M -$30.57M
Basic EPS -$3.78 -$2.88 -$3.95 -$3.26 -$3.90 -$3.80 -$2.48 -$2.12 -$1.00
Diluted EPS -$3.78 -$2.88 -$3.95 -$3.26 -$3.90 -$3.80 -$2.48 -$2.12 -$1.00
Basic Shares Outstanding 191.5M 186.1M 162.8M 147.5M 144.4M 118.0M 105.1M 61.8M 30.6M
Diluted Shares Outstanding 191.5M 186.1M 162.8M 147.5M 144.4M 118.0M 105.1M 61.8M 30.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $353.2M $243.7M $194.5M $154.2M $120.7M $110.6M $116.6M $5.88M
Cost of Revenue $20.45M $15.05M $9.94M $8.11M $6.56M $3.65M $2.64M $2.08M
Gross Profit $332.7M $228.6M $184.6M $146.1M $114.1M $106.9M $114.0M $3.80M
Research & Development $143.5M $149.4M $126.6M $116.4M $112.9M $111.2M $111.4M $130.3M
Selling, General & Admin $200.9M $186.3M $163.9M $158.1M $137.6M $129.2M $106.4M $94.78M
Operating Income -$11.64M -$107.1M -$106.0M -$139.6M -$145.2M -$134.3M -$104.4M -$226.0M
EBITDA -$10.57M -$106.0M -$104.8M -$138.1M -$143.8M -$133.0M -$103.1M -$224.7M
Interest Income $13.11M $6.66M $6.25M $4.33M $6.24M $3.90M $5.38M $4.68M
Interest Expense $13.26M $13.28M $12.94M $11.64M $11.74M $11.61M $18.12M $21.52M
Income Before Tax -$59.27M -$155.9M -- -- -$186.5M -$181.7M -- --
Income Tax Expense $1.23M $0 -- -$120K -$1.54M $2.10M $0 $1.15M
Net Income -$56.71M -$152.2M -$164.0M -$192.9M -$182.7M -$181.9M -$167.4M -$265.1M
Basic EPS -$0.42 -$0.78 -$0.84 -- -$0.95 -$0.95 -$0.88 --
Diluted EPS -$0.42 -$0.78 -$0.84 -- -$0.95 -$0.95 -$0.88 --
Basic Shares Outstanding 196.0M 195.8M 194.8M -- 191.9M 190.5M 190.1M --
Diluted Shares Outstanding 196.0M 195.8M 194.8M -- 191.9M 190.5M 190.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $570.1M $681.1M $375.9M $376.7M $393.8M $356.1M $363.8M $436.1M
Short-Term Investments $17.36M $0 $0 $51.58M $393.7M $251.0M $182.2M --
Cash & Short-Term Investments $587.5M $681.1M $375.9M $428.3M $787.5M $607.1M $546.0M $436.1M
Accounts Receivable, Net $139.4M $4.72M $1.75M -- -- -- -- --
Inventory $26.75M $0 -- -- -- -- -- --
Other Current Assets -- -- -- -- -- -- -- $2.05M
Total Current Assets $797.7M $720.7M $477.6M $548.9M $888.9M $642.8M $568.6M $445.2M
Property, Plant & Equipment, Net $5.37M $7.01M $11.82M $14.57M $30.07M $20.32M $5.62M $1.57M
Intangible Assets $28.08M $23.93M $26.32M $28.71M $44.93M $0 -- --
Long-Term Investments -- -- -- -- -- -- $31.14M --
Other Non-Current Assets $16.71M $18.20M $22.62M $20.22M $33.03M $23.93M $26.29M $1.09M
Total Non-Current Assets $138.3M $198.6M $68.79M $74.18M $123.9M $60.76M $63.06M $19.72M
Total Assets $936.0M $919.3M $546.4M $623.0M $1.01B $703.6M $631.7M $464.9M
Accounts Payable $36.23M $9.62M $10.65M $11.56M $11.88M $8.95M $8.85M $13.51M
Short-Term Debt -- -- -- -- -- $1.46M -- --
Deferred Revenue (Current) $7.19M $14.60M $6.10M $8.16M $0 -- -- --
Other Current Liabilities $120.2M $33.07M -- -- -- -- -- --
Total Current Liabilities $288.0M $154.4M $143.8M $121.4M $135.1M $95.65M $60.38M $32.58M
Long-Term Debt $2.01B $437.3M $446.4M $431.0M $430.8M $92.42M $91.79M $54.51M
Deferred Revenue (Non-Current) $13.08M $17.09M $3.73M -- -- -- -- --
Other Non-Current Liabilities $244K $286K $5.63M $26.64M $22.07M $9.52M $3.53M $495K
Total Non-Current Liabilities $2.72B $2.22B $1.75B $1.75B $1.74B $500.1M $95.32M $55.00M
Total Liabilities $3.01B $2.38B $1.89B $1.87B $1.88B $595.7M $155.7M $87.58M
Total Debt (incl. Leases) $2.02B $446.5M $459.6M $446.9M $454.7M $114.1M $99.79M $54.51M
Common Stock $202K $196K $181K $157K $154K $125K $124K $92K
Retained Earnings -$3.82B -$3.10B -$2.56B -$1.92B -$1.44B -$888.8M -$440.0M -$179.4M
Accumulated Other Comp. Income $12K $8.0K $31K -$328K -$132K $192K $254K --
Total Stockholders' Equity -$2.09B -$1.47B -$1.35B -$1.25B -$870.4M $57.91M $408.5M $314.9M
Total Equity -$2.08B -$1.46B -$1.34B -$1.24B -$867.0M $106.3M $473.7M $377.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $1.53B $677.9M $879.9M $570.1M $643.0M $749.0M $540.6M $681.1M
Short-Term Investments $5.49M $42.25M $60.30M $17.36M $2.99M $7.94M -- $0
Cash & Short-Term Investments $1.54B $720.2M $940.2M $587.5M $645.9M $756.9M $540.6M $681.1M
Accounts Receivable, Net $375.1M $254.5M $205.2M $139.4M $116.5M $76.87M $115.3M $4.72M
Inventory $59.72M $52.84M $32.98M $26.75M $24.53M $18.28M $3.95M $0
Total Current Assets $2.04B $1.09B $1.24B $797.7M $839.4M $912.3M $695.2M $720.7M
Property, Plant & Equipment, Net $5.04M $5.23M $4.94M $5.37M $5.83M $6.11M $6.70M $7.01M
Intangible Assets $25.92M $26.64M $27.36M $28.08M $28.80M $29.51M $27.80M $23.93M
Other Non-Current Assets $22.69M $20.12M $18.62M $16.71M $25.52M $18.11M $16.61M $18.20M
Total Non-Current Assets $117.2M $124.2M $129.7M $138.3M $158.9M $167.9M $186.5M $198.6M
Total Assets $2.16B $1.22B $1.37B $936.0M $998.2M $1.08B $881.6M $919.3M
Accounts Payable $88.26M $27.20M $29.06M $36.23M $18.70M $26.13M $27.52M $9.62M
Deferred Revenue (Current) $4.74M $5.55M $6.12M $7.19M $9.09M $10.54M $11.62M $14.60M
Other Current Liabilities $212.1M $192.2M $135.5M $120.2M $92.74M $65.92M $40.67M $33.07M
Total Current Liabilities $977.2M $890.6M $816.4M $288.0M $216.6M $175.9M $152.1M $154.4M
Long-Term Debt $2.63B $2.65B $2.65B $2.01B $2.01B $0 $0 $437.3M
Deferred Revenue (Non-Current) $8.97M $10.42M $11.78M $13.08M $13.13M $14.67M $17.51M $17.09M
Other Non-Current Liabilities $1.41M $240K $229K $244K $679K $545K $352K $286K
Total Non-Current Liabilities $2.84B $2.83B $2.82B $2.72B $2.70B $2.68B $2.37B $2.22B
Total Liabilities $3.82B $3.72B $3.64B $3.01B $2.92B $2.86B $2.52B $2.38B
Total Debt (incl. Leases) $2.65B $2.67B $2.67B $2.02B $2.02B $8.81M $10.12M $446.5M
Common Stock $207K $206K $204K $202K $200K $198K $197K $196K
Retained Earnings -$4.19B -$4.14B -$3.99B -$3.82B -$3.63B -$3.45B -$3.26B -$3.10B
Accumulated Other Comp. Income -$95K -$7.0K -$8.0K $12K $2.0K $1.0K $0 $8.0K
Total Stockholders' Equity -$1.66B -$2.52B -$2.28B -$2.09B -$1.93B -$1.79B -$1.65B -$1.47B
Total Equity -$1.65B -$2.50B -$2.27B -$2.08B -$1.92B -$1.78B -$1.64B -$1.46B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$732.9M -$543.3M -$653.3M -$484.7M -$586.5M -$505.5M -$288.6M -$169.5M -$43.83M
Depreciation & Amortization $5.43M $6.08M $6.49M $6.77M $5.84M $1.46M $859K -- --
Stock-Based Compensation $133.0M $95.80M $108.7M $91.56M $99.50M $58.46M $21.37M $6.07M $1.84M
Change in Receivables -$134.7M -$2.97M $15.33M $15.17M -- -- -- -- --
Change in Inventory -$25.31M $0 $0 -- -- -- -- -- --
Change in Payables $26.61M $1.51M $2.78M -$349K $2.83M -$735K -$4.66M $16.70M $1.58M
Operating Cash Flow -$445.9M -$520.7M -$527.7M -$419.5M -$497.9M -$399.7M -$253.6M -$136.6M -$40.49M
Capital Expenditure -$1.10M -$933K -$1.31M -$4.82M -$13.25M -$7.52M -$2.64M -$2.18M -$464K
Free Cash Flow -$447.0M -$521.7M -$529.0M -$424.3M -$511.2M -$407.2M -$256.2M -$138.8M -$40.95M
Purchases of Investments -$28.20M -$93.81M -$29.73M -$137.5M -$589.9M -$287.9M -$212.9M -- --
Investing Cash Flow -$24.49M $60.78M $54.03M $453.1M -$200.8M -$52.99M -$217.3M -$21.04M -$464K
Common Stock Issued $0 $314.7M $449.8M $4.85M $0 $0 -- -- --
Share Repurchases -$48.28M $0 $0 $0 -$200.0M -$75.00M -- -- --
Dividends Paid -- -- -- -- -- -- -$997K -- -$1.15M
Financing Cash Flow $359.3M $748.5M $451.5M -$13.13M $736.4M $447.2M $398.8M $501.5M $113.0M
Net Change in Cash -$111.1M $288.5M -$22.15M $20.52M $37.69M -$5.52M -$72.05M $343.9M $72.03M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$60.50M -$155.9M -$166.6M -$194.6M -$184.9M -$183.8M -$169.6M -$267.4M
Depreciation & Amortization $1.07M $1.05M $1.19M $1.44M $1.40M $1.32M $1.28M $1.37M
Stock-Based Compensation $39.86M $44.07M $33.24M $34.64M $35.26M $37.24M $25.88M $30.13M
Change in Receivables -$120.6M -$49.26M -$65.78M -$22.93M -$39.65M $38.40M -$110.5M -$4.24M
Change in Inventory -$7.47M -$21.11M -$7.05M -$1.95M -$6.77M -$13.39M -$3.19M $0
Change in Payables $61.02M -$1.86M -$7.17M $17.52M -$7.43M -$1.05M $17.57M -$3.75M
Operating Cash Flow -$44.17M -$71.10M -$197.3M -$56.42M -$109.6M -$80.68M -$199.2M -$195.3M
Capital Expenditure -$290K -$443K -$69K -$33K -$470K -$594K $0 -$47K
Free Cash Flow -$44.46M -$71.54M -$197.3M -$56.45M -$110.0M -$81.28M -$199.2M -$195.4M
Purchases of Investments $0 -$11.27M -$52.67M -$17.32M -$2.97M -$7.91M $0 $0
Investing Cash Flow $36.61M $17.89M -$42.73M -$14.35M $4.46M -$13.00M -$1.59M -$3.24M
Common Stock Issued -- -- -- $0 $0 $0 $0 $0
Share Repurchases -$42.50M -$127.5M -$82.50M $0 $0 $0 -$48.28M $0
Financing Cash Flow $863.0M -$148.8M $549.9M -$2.18M -$894K $302.0M $60.33M $473.9M
Net Change in Cash $855.5M -$202.0M $309.9M -$72.96M -$106.0M $208.4M -$140.5M $275.4M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 95.8% 98.3% 73.7% 95.6% 95.5% -- -- -- --
Operating Margin -104.2% -267.2% -6528.8% -659.6% -827.1% -5752.0% -656.4% -- --
Net Profit Margin -144.4% -241.4% -6913.9% -619.7% -806.9% -5439.7% -642.5% -- --
Return on Equity (ROE) -- -- -- -- -- -774.9% -63.8% -41.5% --
Return on Assets (ROA) -77.4% -58.3% -117.7% -77.2% -55.5% -63.8% -41.3% -28.1% --
Current Ratio 2.77x 4.67x 3.32x 4.52x 6.58x 6.72x 9.42x 13.67x --
Quick Ratio 2.68x 4.67x 2.63x 3.53x 5.83x 6.35x 9.04x 13.39x --
Debt to Equity -- -- -- -- -- 1.97x 0.24x 0.17x --
Revenue Growth (YoY) +126.3% +2285.3% -88.0% +11.4% +745.1% -79.7% -- -- --
Gross Profit Growth (YoY) +120.7% +3079.6% -90.8% +11.4% -- -- -- -- --
5Y Revenue / Share Growth +3649.8% +209.0% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 94.3% 94.4% 95.1% 95.8% 95.8% 96.2% 95.4% 98.3%
Operating Margin -38.5% -69.8% -90.5% -104.2% -172.4% -278.4% -547.6% -267.2%
Net Profit Margin -59.8% -97.0% -124.4% -144.4% -225.3% -329.3% -524.2% -241.4%
Return on Assets (ROA) -26.2% -56.8% -52.6% -77.4% -79.9% -71.9% -75.8% -58.3%
Current Ratio 2.09x 1.23x 1.52x 2.77x 3.88x 5.19x 4.57x 4.67x
Quick Ratio 2.03x 1.17x 1.48x 2.68x 3.76x 5.08x 4.54x 4.67x
Revenue Growth (YoY) +192.6% +120.4% +66.8% +2521.2% +4318.0% +4999.9% -44.8% +237.1%
Gross Profit Growth (YoY) +191.5% +113.8% +61.9% +3746.0% +5248.5% +6709.7% -45.9% +231.1%
Operating Income Growth (YoY) -- -- -- -- -- -- -30529.2% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -208.0% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -208.9% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001743881) · from December 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:07 UTC · Open in terminal